Current treatment for adrenal insufficiency in neonates and infants is unsatisfactory as unlicensed adult formulations are used and the minimum unit dose available is a scored 5mg hydrocortisone tablet. These are difficult to administer to neonates and give rise to inconsistencies in dose as content uniformity of crushed tablets cannot be verified. We have developed a new formulation, Infacort®, specifically designed for infants and neonates… more
https://endo.confex.com/endo/2014endo/webprogram/Paper15058.html
http://www.tain-project.org/media/16432/ukicrs_infacort_poster__final_.pdf
